Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 360

Anogenital Warts

NICE CKS Warts – anogenital. Last revised: May 2024.

BASHH Anogenital warts 2024. Last updated: Aug 2024.

Definition

Anogenital warts are benign, proliferative growths occurring in the genital, perineal, anal, and perianal areas.

Aetiology

Anogenital warts are caused by human papillomavirus (HPV)

  • Most commonly caused by low-risk, non-oncogenic genotypes 6 and 11
  • In contrast, high-risk, oncogenic genotypes 16, 18, 31, 33 are associated with cervical cancer and anal cancer.

HPV is transmitted through direct skin-to-skin contact

  • Most common: sexual contact
  • Rarely: from hand warts or perinatally
  • Orogenital transmission is also possible

Clinical Features

Morphological types There are 4 main morphological types:

  • Condylomata acuminata* (most typical) – flesh-coloured, soft, cauliflower-like growth (exophytic papillomatous surface)
  • Keratotic warts – thickened consistency appearing as horny papules (often non-pigmented)
  • Flat warts – macular (flat) lesions (often non-pigmented)
  • Papular warts – solid papular (raised) lesions (often non-pigmented)

*Condylomata acuminata is NOT the same as condylomata lata, which is seen in secondary syphilis

Other features:

  • Broad-based or pedunculated
  • Single or multiple
  • Typically <1 cm but may coalesce into larger plaques
  • Other possible colours: whitish, erythematous, hyperpigmented
Distribution / location Commonly occur in areas of friction, anywhere throughout the anogenital skin and mucosa.

Common sites include:

  • Vulva, vagina, and cervix
  • Urethral meatus
  • Penis (under the foreskin of uncircumcised penis, shaft of the circumcised penis)
  • External genitalia and perianal region
Symptoms Usually asymptomatic

If symptomatic:

  • Local irritation or discomfort
  • Pain (if traumatised)
  • Bleeding (due to friction)
  • Urinary symptoms (if urethral involvement):
    • Abnormal urinary stream
    • Terminal haematuria

Complications

Anogenital warts are associated with increased risk of cervical and anal cancer.

Note that this is primarily due to co-infection with high-risk HPV types (16, 18, 31, 33) rather than the wart-causing types (6, 11) themselves.

Investigation and Diagnosis

Anogenital warts are primarily a clinical diagnosis

Other examinations / investigations:

  • Dermatoscope / colposcope can be useful for identifying small lesions
  • DRE and proctoscopy should be offered if warts are at the anal margin / anal symptoms are present
  • Speculum examination is required if internal warts are suspected
  • Colposcopy is recommended for all suspected HPV-related cervical lesions to differentiate between low-grade and high-grade lesions
  • Urgent biopsy is recommended for atypical features (e.g. bleeding, ulceration, any clinical suspicion of malignancy) / diagnostic uncertainty / non-response to treatment

Management

General Advice / Conservative Management

Advice on risk reduction:

  • Recommend consistent condom use to reduce onward transmission
  • Provide smoking cessation advice (as smoking is associated with higher recurrence)

Partner Notification and Management

Internal Warts: Surgical/ablative treatments (laser, electrosurgery, excision) should be offered first-line as these areas are less accessible for topical application

Routine evaluation or notification of sexual partners is NOT required.

Pharmacological Management – General Population

Key factors that influence the choice of treatment:

  • Internal vs external warts
    • Internal warts = ablative therapy (laser / electrosurgery / excision) is explicitly 1st line
    • External warts = topical therapy or cryotherapy
  • Recurrent warts = ablative therapy is preferred
  • Persistent warts = switch to an alternative therapy
  • Pregnancy
    • AVOID self-applied (topical) treatments
    • Safe options: ablative therapy (laser / electrosurgery / excision) / cryotherapy / TCAA
    • Ablative therapy is generally preferred over the other options
  • Surgical excision is particularly useful for a small number of warts or pedunculated lesions

Self-applied (topical) treatments:

Treatment Recommended situation / preference
Podophyllotoxin (solution / cream) Preferred 1st choice due to lower cost, shorter treatment duration, and faster action

Solution vs cream:

  • Solution is preferred at easy-to-reach sites
  • Cream is preferred for external perianal warts
Imiquimod 5% cream Recommended for external warts (equivalent safety / efficacy to podophyllotoxin)

Preferred for reducing recurrence following CO2 laser treatment

Sinecatechins 10% ointment Recommended for external warts

Note that frequent dosing (3x daily) may impair patient adherence

Clinician-applied (topical and ablative) treatments:

Treatment Recommended situation / preference
Ablative therapy (laser / electrosurgery / excision) Description: one-session performed under local anaesthetic

1st line for:

  • All internal warts (e.g. urethral, vaginal, cervical, anal), and
  • Resistant / recurrent warts

Offers the highest clearance rates

Safe in pregnancy

Cryotherapy
  • Recommended for external warts
  • Safe in pregnancy
  • Safe for internal vaginal / cervical / anal warts
TCAA 80-90%
  • Recommended for external warts
  • Suitable for internal vaginal / cervical / anal warts
  • Safe in pregnancy
Nitrizinc complex May be considered when other recommended treatments failed / unsuitable

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD